Western Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,484
| Closed | -$227K | – | 680 |
|
|
2024
Q4 | $227K | Sell |
1,484
-100
| -6% | -$15.3K | 0.01% | 602 |
|
|
2024
Q3 | $307K | Sell |
1,584
-53
| -3% | -$10.3K | 0.02% | 588 |
|
|
2024
Q2 | $379K | Sell |
1,637
-30
| -2% | -$6.96K | 0.03% | 432 |
|
|
2024
Q1 | $359K | Buy |
1,667
+136
| +9% | +$29.3K | 0.03% | 449 |
|
|
2023
Q4 | $396K | Buy |
1,531
+7
| +0.5% | +$1.81K | 0.03% | 466 |
|
|
2023
Q3 | $392K | Sell |
1,524
-47
| -3% | -$12.1K | 0.03% | 440 |
|
|
2023
Q2 | $448K | Sell |
1,571
-2
| -0.1% | -$570 | 0.04% | 400 |
|
|
2023
Q1 | $437K | Sell |
1,573
-5
| -0.3% | -$1.39K | 0.04% | 401 |
|
|
2022
Q4 | $437K | Sell |
1,578
-1,135
| -42% | -$314K | 0.04% | 367 |
|
|
2022
Q3 | $727K | Sell |
2,713
-1,602
| -37% | -$429K | 0.04% | 388 |
|
|
2022
Q2 | $877K | Sell |
4,315
-375
| -8% | -$76.2K | 0.05% | 332 |
|
|
2022
Q1 | $988K | Buy |
4,690
+3,200
| +215% | +$674K | 0.05% | 336 |
|
|
2021
Q4 | $352K | Buy |
+1,490
| New | +$352K | 0.03% | 419 |
|
|
2021
Q2 | $397K | Buy |
1,147
+104
| +10% | +$36K | 0.04% | 418 |
|
|
2021
Q1 | $292K | Sell |
1,043
-127
| -11% | -$35.6K | 0.04% | 407 |
|
|
2020
Q4 | $286K | Buy |
1,170
+2
| +0.2% | +$489 | 0.04% | 366 |
|
|
2020
Q3 | $331K | Buy |
1,168
+49
| +4% | +$13.9K | 0.05% | 315 |
|
|
2020
Q2 | $299K | Sell |
1,119
-3
| -0.3% | -$802 | 0.05% | 313 |
|
|
2020
Q1 | $357K | Buy |
1,122
+199
| +22% | +$63.3K | 0.08% | 240 |
|
|
2019
Q4 | $274K | Hold |
923
| – | – | 0.04% | 330 |
|
|
2019
Q3 | $213K | Buy |
+923
| New | +$213K | 0.04% | 363 |
|
|
2019
Q1 | – | Sell |
-740
| Closed | -$227K | – | 379 |
|
|
2018
Q4 | $227K | Buy |
+740
| New | +$227K | 0.06% | 302 |
|